Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.31 |
| ▸ | PPARA | Q07869 | 5/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23318768 | 0.97 | CA12 (0.32) | PPARGPPARACHRNB4CHRNA3CHRNA7 | |
| SCHEMBL23318835 | 0.97 | CA12 (0.32) | PPARGPPARACHRNB4CHRNA3CHRNA7 | |
| SCHEMBL23318691 | 0.94 | PPARG (0.30) | PPARGPPARA | |
| SCHEMBL23318617 | 0.94 | CHRNB4 (0.31) | CHRNB4CHRNA3CHRNA7CA12CA1 | |
| SCHEMBL23318919 | 0.93 | MCL1 (0.33) | CHRNB4CHRNA3CA12CA1CA2 | |
| SCHEMBL25452318 | 0.92 | — | — | |
| SCHEMBL23319018 | 0.92 | CHRNB4 (0.31) | CHRNB4CHRNA3CHRNA7 | |
| SCHEMBL23318885 | 0.92 | CHRNA1 (0.33) | CHRNB4CHRNA3 | |
| SCHEMBL23318610 | 0.92 | SIGMAR1 (0.30) | — | |
| SCHEMBL23319088 | 0.92 | CHRNB4 (0.32) | PPARGPPARACHRNB4CHRNA3CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3826080-B1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MAT CO LTD (CN) | 2022-05-11 | — | — | EP | disclosed |
| EP-3826080-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE | Shaanxi Lighte Optoelectronics Material Co., Ltd. (CN) | 2021-05-26 | — | — | EP | disclosed |
| US-20210130313-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO. LTD. (CN) | 2021-05-06 | — | — | US | disclosed |
| WO-2021082504-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | 陕西莱特光电材料股份有限公司 | 2021-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210130313-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE | EXOC1, NPM1, EXOC4 | PPARG 4158/4885PPARA 4450/4885CHRNB4 1842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.